Faculty of Health Science, University of Southern Denmark, Odense, Denmark; Department of Ophthalmology, Odense University Hospital, Odense, Denmark.
Acta Ophthalmol. 2014 Mar;92 Thesis 2:1-21. doi: 10.1111/aos.12385.
Surgical correction of refractive errors is becoming increasingly popular. In the 1990s, the excimer laser revolutionized the field of corneal refractive surgery with PRK and LASIK, and lately refractive lenticule extraction (ReLEx) of intracorneal tissue, using only a femtosecond laser, has become possible. Two new procedures were developed, ReLEx flex (FLEX) and ReLEx smile (SMILE). Until this thesis, only a few long-term studies of PRK with a relatively limited number of patients had been published; therefore, this thesis intended to retrospectively evaluate long-term outcomes after PRK for all degrees of myopia for a large number of patients. Furthermore, a prospective contralateral eye study comparing FLEX and SMILE, when treating high to moderate degrees of myopia, had not been performed prior to this study. This was the second aim of this thesis. In the first study, results from 160 PRK patients (289 eyes) were presented. Preoperative spherical equivalent ranged from -1.25 to -20.25 D, with 78% having low myopia (<-6 D). Average follow-up time was 16 years (range 13-19 years), making this the longest published follow-up study on PRK patients. Outcomes from eyes with low myopia were generally superior to outcomes from eyes with high myopia, at final follow-up. Seventy-two percent were within ± 1.00 D of target refraction, as compared to 47% of eyes with high myopia. However, results from a subgroup of unilateral treated PRK patients indicated that refraction at final follow-up was affected by myopic progression. Fifty percent of eyes with low myopia had uncorrected 20/20 distance visual acuity or better, as compared to 22% of eyes with high myopia. Haze did not occur if attempted corrections were <-4 D, and only eyes with high myopia lost two lines or more of CDVA (corrected distance visual acuity). Eighty-one per cent were satisfied or very satisfied with their surgery.
The results support the continued use of the excimer laser for corneal surface ablation as a treatment option for correction of low degrees of myopia, and as the treatment of choice for subgroups of refractive patients (thin corneas, etc.). The results also highlight that treatment of higher degrees of myopia with standard PRK should only be done today under special circumstances, due to low refractive predictability, and high risk of corneal haze. Technological advances since then should be taken into account when comparing these results with contemporary techniques. In the second study, 35 patients were randomized to receive FLEX in one eye and SMILE in the other. Preoperative spherical equivalent refraction ranged from -6 to -10 D with low degrees of astigmatism. A total of 34 patients completed the 6 month follow-up period. Refractive and visual outcomes were very similar for the two methods, as well as tear film measurements and changes in corneal biomechanics. Ninety-seven percent were within ± 1.00 D of target refraction, no eyes lost two lines or more of CDVA, and contrast sensitivity was unaffected after both procedures. The changes in higher-order aberrations were also very similar. There were also no differences in tear film parameters 6 months after surgery, although less postoperative foreign body sensation was reported within the first week after surgery in SMILE eyes. Corneal sublayer pachymetry measurements demonstrated equally increased epithelial thickness 6 months after surgery. Contrary to expectations, it was not possible to measure the theoretical biomechanical advantages of a small corneal incision in SMILE as compared to a corneal flap in FLEX. The main differences between FLEX and SMILE were found when the corneal nerves and intraoperative complications were evaluated. Thus, corneal sensitivity was better preserved and corneal nerve morphology was less affected after SMILE, but intraoperative complications occurred more frequently, although without visual sequela. Finally, 97% were satisfied or very satisfied with both their surgeries.
The results support the continued use of both FLEX and SMILE for treatment of up to high degrees of myopia. Overall, refractive and visual results for both procedures were good and similar, but from a biological point of view, the less invasive SMILE technique is more attractive, as demonstrated in this study, despite being slightly more surgically demanding than FLEX.
屈光不正的手术矫正越来越受欢迎。在 20 世纪 90 年代,准分子激光通过 PRK 和 LASIK 彻底改变了角膜屈光手术领域,最近,仅使用飞秒激光,就可以进行眼内组织的屈光性透镜切除术(ReLEx)。已经开发出两种新的手术,ReLEx flex(FLEX)和 ReLEx smile(SMILE)。直到本论文,只有少数几项关于 PRK 的长期研究,并且研究对象数量有限;因此,本论文旨在回顾性评估大量患者的 PRK 治疗所有程度近视的长期结果。此外,在这项研究之前,还没有进行过关于高到中度近视的 FLEX 和 SMILE 的前瞻性对侧眼研究。这是本论文的第二个目的。在第一项研究中,展示了 160 名 PRK 患者(289 只眼)的结果。术前等效球镜度数范围从-1.25 到-20.25 D,78%为低度近视(<-6 D)。平均随访时间为 16 年(范围 13-19 年),这是 PRK 患者最长的已发表随访研究。低度近视眼的结果通常优于高度近视眼的结果,在最终随访时。72%的患者在目标屈光度的± 1.00 D 以内,而高度近视眼的比例为 47%。然而,单侧接受 PRK 治疗的患者亚组的结果表明,最终随访时的屈光度受近视进展的影响。50%的低度近视患者有未矫正的 20/20 远视力或更好,而高度近视眼的比例为 22%。如果尝试的矫正值<-4 D,则不会出现混浊,只有高度近视眼会损失两线或更多的 CDVA(矫正远视力)。81%的患者对手术结果满意或非常满意。
结果支持继续使用准分子激光进行角膜表面消融,作为矫正低度近视的一种治疗选择,也是屈光患者(薄角膜等)的治疗选择。结果还强调,由于屈光预测性低和角膜混浊风险高,应仅在特殊情况下,对高度近视患者进行标准 PRK 治疗。在比较这些结果与当代技术时,应考虑到此后的技术进步。在第二项研究中,35 名患者随机接受 FLEX 治疗一只眼,SMILE 治疗另一只眼。术前等效球镜屈光度范围从-6 到-10 D,伴有低度散光。共有 34 名患者完成了 6 个月的随访期。两种方法的屈光和视觉结果非常相似,以及泪膜测量和角膜生物力学的变化。97%的患者在目标屈光度的± 1.00 D 以内,没有患者损失两线或更多的 CDVA,两种手术后对比敏感度均不受影响。高阶像差的变化也非常相似。手术后 6 个月,泪膜参数也没有差异,尽管 SMILE 眼术后一周内报告的术后异物感较少。角膜亚层厚度测量显示,术后 6 个月上皮厚度同样增加。与预期相反,由于在 FLEX 中角膜瓣,无法测量 SMILE 中角膜小切口的理论生物力学优势。FLEX 和 SMILE 之间的主要区别在于评估角膜神经和术中并发症时。因此,SMILE 术后角膜敏感性更好,角膜神经形态学受影响较小,但术中并发症更频繁发生,尽管没有视觉后遗症。最后,97%的患者对两种手术都满意或非常满意。
结果支持继续使用 FLEX 和 SMILE 治疗高达高度近视的患者。总的来说,两种手术的屈光和视觉结果都很好且相似,但从生物学角度来看,侵入性较小的 SMILE 技术更具吸引力,正如本研究所示,尽管与 FLEX 相比,SMILE 手术的技术要求稍高。